Congress signals push for mental health parity and suicide prevention funding
H.Res. 671 — Prioritizing mental health to the same degree as physical health to address the epidemics of suicide and drug overdose in the United States. · Filed by Shri Thanedar (D-MI) · 4 cosponsors · Introduced Sep 2, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This is a House resolution expressing support for treating mental health with the same priority as physical health in the United States. It calls on Congress to enforce existing mental health parity laws in insurance, reduce stigma around mental illness, support the 2024 National Strategy for Suicide Prevention, and increase funding and resources for mental health services, medication-assisted treatment, crisis care, and suicide prevention programs.
Why we flagged it
This is a non-binding resolution expressing congressional support for mental health parity, stigma reduction, and expanded suicide/overdose prevention funding. It contains no legislative mechanism, appropriations, or regulatory change—only statements of support and calls for action.
What the text implies
- As a non-binding resolution, this has no direct legal force but may signal congressional intent to appropriate funds or pass binding legislation on mental health in future bills.
- The emphasis on 'full enforcement of existing Federal laws' regarding mental health parity suggests potential future regulatory action or oversight of insurance companies' compliance with the Mental Health Parity and Addiction Equity Act.
- The call to 'provide as many resources and funds as possible' could presage budget requests or appropriations riders in future spending bills, potentially affecting pharmaceutical and healthcare service providers.
Who it affects
The resolution advocates for stronger enforcement of existing mental health parity protections, expanded access to treatment and crisis services, and increased funding for suicide and overdose prevention—all of which would benefit ordinary citizens struggling with mental health conditions or substance use disorders. The focus on reducing stigma and improving access to care addresses documented public health crises.
Who stands to gain
- pharmaceutical companies (mental health and substance use medications)
- healthcare service providers (mental health clinics, crisis centers)
- medication-assisted treatment providers
- digital health platforms (mental health apps, telehealth services)
Named in the bill
Centers for Disease Control and Prevention (CDC), Substance Abuse and Mental Health Services Administration (SAMHSA), World Health Organization (WHO), Bristol Myers Squibb (BMY), Guardant Health (GH), Pfizer (PFE), DaVita (DVA), Johnson & Johnson (JNJ)
Where it stands
4 cosponsors: 4 Democrats.
- Sep 2, 2025 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
How this was measured
Analysis — Quorum's AI read the full bill text on Jul 6, 2026; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
As of — page rendered 2026-10-20.
“Congress signals push for mental health parity and suicide prevention funding” QuorumCivic. https://share.quorumcivic.app/bill/119/hres671 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.